U.S. Industrial REITs Stock News

Halozyme Therapeutics (NasdaqGS:HALO) announced a global exclusive collaboration and license agreement with Vertex Pharmaceuticals for its Hypercon technology. The agreement allows Vertex to use Hypercon for up to three drug targets, with Halozyme eligible for upfront payments, potential milestones, and royalties. The deal broadens Halozyme’s technology portfolio beyond its existing ENHANZE franchise into an additional platform offering. Halozyme Therapeutics focuses on drug delivery...

In the past week, Hewlett Packard Enterprise reported a strong first quarter with double-digit revenue growth and earnings ahead of expectations, while also raising its outlook for Networking and full-year free cash flow. Alongside this, HPE’s evolving AI and networking ecosystem, from updated UALink specifications to new Wi-Fi patent licenses and AI partnerships, highlights how the company is positioning its infrastructure for emerging workloads and enterprise needs. Next, we’ll examine how...

The Buckle, Inc. reported that for the 5-week period ended April 4, 2026, comparable store net sales rose 7.0% and total net sales increased 8.2% to US$118.0 million, with year-to-date net sales for the 9-week period up 8.5% to US$202.5 million versus the prior year. Alongside these stronger sales trends, Buckle elevated long-time executive Scott A. Werth to Senior Vice President of Stores, placing its more than 7,000-person sales team under experienced, internally developed leadership...

Why Omnicom Group is Back on Investors’ Radar Omnicom Group (OMC) is drawing investor attention after recent share price swings, with the stock showing mixed returns over the past year and contrasting signals from its latest revenue, profit figures, and valuation metrics. See our latest analysis for Omnicom Group. The recent share price pullback, with a 1 month share price return of a 7.53% decline and a year to date share price return of a 7.92% decline, contrasts with a 1 year total...

If you are wondering whether FuboTV's share price lines up with its underlying worth, this breakdown will help you frame that question in a clear and practical way. The stock last closed at US$12.04, with a recent 7 day return of 23.2%, a 30 day return of 14.2%, a year to date return of 61.3%, a 1 year return of 63.6%, and a 5 year return of 94.8%. These mixed returns have kept FuboTV on the radar of investors who want to understand whether recent price action reflects changing expectations...

SM Energy (SM) recently completed a cash tender offer for up to US$1b of 8.375% senior notes due 2028, drawing fresh attention to the stock just as sentiment around oil and its earnings outlook shifts. See our latest analysis for SM Energy. Those tender offer results come at a time when SM Energy's share price has pulled back 1.7% on the day and 7.5% over the past week, but still shows a 59.3% 3 month share price return and a 77.8% 5 year total shareholder return. This suggests that long term...

If you have been wondering whether Marsh & McLennan Companies at around US$173 a share is a fair deal or not, this article walks through what the current price might be implying about value. The stock has slipped around 0.8% over the last week, 0.5% over the last month and 5.1% year to date, with a 22.9% decline over the past year contrasted against 5.4% and 47.1% returns over the past 3 and 5 years. Recent news around Marsh & McLennan Companies has focused on the business as a major...

PDD Holdings’ Q4 2025 results, released in late March, showed earnings per share of 17.69 and revenue of CN¥123.91 billion, both below analyst expectations, amid pressure from competition, economic softness, and heavy supply chain investments. At the same time, the group is confronting heightened regulatory scrutiny in China and abroad, including investigations and potential changes to import duty rules that could affect its Temu platform and broader operations. We’ll now examine how this...

Revenue beat and growth outlook put Standex International (SXI) in focus Standex International (SXI) is on investors’ radar after reporting a 16.6% year-on-year revenue increase that topped analyst expectations, coupled with guidance pointing to mid to high single digit organic growth. See our latest analysis for Standex International. Alongside the guidance update, the share price has climbed 14.92% over the past 90 days and the 1-year total shareholder return is 97.44%. This indicates that...

McDonald’s (NYSE:MCD) has launched its McValue 2.0 menu across the US, featuring an Under $3 Menu and new bundled meal deals. The company is pairing these offers with fresh pop culture collaborations, including KPop Demon Hunters themed meals. McDonald’s has also appointed new senior executives to strengthen its leadership team as affordability pressures remain in focus. For you as an investor, McDonald’s sits at the intersection of quick service dining, branding, and real estate, where...

Atlassian (NasdaqGS:TEAM) has launched new AI capabilities in Confluence, including an open beta of Remix, a tool that turns static text into visual stories. The company has also introduced pre-built third party agents that connect Confluence with partner apps such as Lovable, Replit, and Gamma for automatic content transformation and workflow integration. For Atlassian, known for collaboration products like Confluence and Jira, this move pushes its core knowledge product toward a more...

Recent performance snapshot for Stewart Information Services With no single headline event driving attention, Stewart Information Services (STC) has attracted interest based on its recent share performance, including a 1.2% gain over the past day and 7.8% over the past week. See our latest analysis for Stewart Information Services. That recent upswing comes after a softer patch, with the share price showing a 4.9% decline over three months and a 6.8% decline year to date, while longer term...

Harmony Biosciences Holdings (HRMY) is in focus after appointing Peter Anastasiou as Chief Operating Officer, adding Troy Ignelzi to the Board, and nominating Geno J. Germano for election at the 2026 shareholder meeting. See our latest analysis for Harmony Biosciences Holdings. The recent leadership reshuffle comes as Harmony Biosciences trades at US$29.16, with a 7 day share price return of 5.12% contrasting with a 90 day share price decline of 24.36% and a relatively flat 1 year total...

In early April 2026, semiconductor materials supplier Entegris benefited as the de-escalation of the U.S.-Iran conflict reopened the Strait of Hormuz, a key route for noble gases and other inputs used in chip fabrication. This development directly reinforces Entegris’ role in securing critical materials integrity for advanced semiconductor manufacturing, at a time when hedge fund interest highlights its importance in the supply chain. We’ll now examine how restored access to critical...

In late March 2026, a Chicago jury ordered Abbott Laboratories to pay US$53 million in compensatory damages to families alleging the company failed to adequately warn that its cow’s milk-based formula for premature infants could cause necrotizing enterocolitis, a potentially deadly bowel disease. This verdict, with punitive damages still to be determined, raises fresh questions about Abbott’s legal exposure, brand perception in infant nutrition, and the potential long-term impact on its...

Eli Lilly's oral GLP-1 obesity pill Foundayo is beginning a broad U.S. launch via Amazon Pharmacy, GoodRx, Ro, Weight Watchers, and LillyDirect. The rollout uses multiple direct-to-consumer and digital health channels, with a focus on home delivery, self-pay options, and integrated clinical support. The move is intended to expand access to oral GLP-1 treatments and could influence how patients obtain and manage obesity therapies. Eli Lilly, traded as NYSE:LLY, is positioning Foundayo as a...

H&R Block (NYSE:HRB) has appointed a new CEO who is steering the company toward a year round financial services platform. The company is prioritizing AI powered tools and technology for both customers and tax professionals as part of this shift. This move marks a change from H&R Block’s traditional focus on seasonal tax preparation. H&R Block, trading at $30.87, is best known for its tax season business, and that reputation is reflected in how many investors think about NYSE:HRB. The stock...

Japan's Financial Services Agency has intensified its inspection of Prudential Holdings of Japan following reports of misconduct. The review focuses on reported issues involving employees and sales practices at the insurer's Japanese operations. The situation raises questions about potential reputational and operational effects for Prudential Financial's international business. For investors watching Prudential Financial (NYSE: PRU), the heightened regulatory attention in Japan comes at a...

On April 1, 2026, Bank OZK’s board declared a higher quarterly cash dividend of US$0.47 per common share and a US$0.28906 preferred dividend, with payments scheduled for April 20 and May 15 respectively to shareholders of record earlier that month. This latest increase marks Bank OZK’s 63rd consecutive quarterly common dividend raise, reinforcing its profile as a persistently income-focused regional bank amid ongoing analyst scrutiny of its credit and growth risks. Next, we’ll examine how...

Investors may be wondering if PHINIA, at around US$74 a share, still offers value or if most of the easy gains are already on the table. The stock is at US$74.03 after returns of 7.9% over the last week, 11.6% over the last month, 14.5% year to date and 98.8% over the past year, which naturally raises questions about what is now priced in. Recent coverage has focused on PHINIA as a listed player in the auto components space, with attention on how the market is responding to its positioning...

In recent months, Iovance Biotherapeutics has reported real-world data for Amtagvi showing higher response and disease control rates than its pivotal trial, reinforcing physician interest in the therapy for advanced melanoma. This stronger real-world performance, combined with advancing trial programs in indications such as non-small cell lung cancer and broader global regulatory reviews, has drawn attention to Amtagvi’s potential to support a wider solid-tumor franchise beyond melanoma...

On 8 April 2026, Rubrik announced it had been selected as the American Hospital Association’s Preferred Cybersecurity Provider, offering a Cyber Resilience Bundle with identity recovery, Microsoft 365 protection, ransomware training, and financial risk analysis to nearly 5,000 member hospitals. This designation gives Rubrik a formal channel into a large portion of the US hospital ecosystem, potentially embedding its tools at the core of how providers maintain operations during cyber...

Comfort Systems USA (NYSE:FIX) is positioned to benefit as energy cost inflation eases following a recent ceasefire agreement between the U.S. and Iran. The expected reopening of the Strait of Hormuz is seen as a key pressure valve for fuel and logistics costs that affect commercial construction and service work. Lower operating costs for customers may support a pickup in deferred maintenance and infrastructure projects, with implications for Comfort Systems USA's margins and...

If you are wondering whether Ryder System's current share price lines up with its underlying worth, this article walks through the key pieces you need to weigh that up. The stock last closed at US$222.04, with returns of 7.8% over 7 days, 9.5% over 30 days, 14.3% year to date, 63.4% over 1 year, 178.6% over 3 years and 221.6% over 5 years. This raises fair questions about how much value is already reflected in the price. Recent attention on Ryder System has focused on how its business model...